Impact of an Insulin Bolus Calculator on Glycemic Control in Relation to Exercise—A Crossover Randomized Controlled Trial
Diabetes Technology & Therapeutics · 2026
DOI: 10.1177/15209156251364547 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Technology & Therapeutics, 2026. Verfasst von Kenney Fehrenkamp Pedersen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Clinical Affairs, Hedia Aps, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Exercise, Hypoglycemic Agents. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Exercise benefits individuals with type 1 diabetes (T1D) but is often hindered by the risk of hypoglycemia. While guidelines provide strategies to mitigate this risk, adherence to recommendations on exercise remains low. Bolus calculators, such as Hedia Diabetes Assistant (HDA), offer a potential way to address this challenge by integrating exercise-related insulin adjustments into daily routines. This trial evaluates the safety and efficacy of HDA in improving glycemic control during exercise.
Methods
This randomized, controlled crossover pilot study included 20 adults diagnosed with T1D for >1 year using multiple daily insulin injections and HbA1c between 42 and 72 mmol/mol (6.0–8.6%). Participants were randomized to first use either HDA (arm A) or their habitual diabetes management (arm B) before and after performing a 45-min moderate-intensity session on an exercise bike and subsequently crossover. The primary outcome was change in time in range (TIR) over the two 24 h periods.
Results
The mean differences (95% confidence interval [CI]) in TIR and time above range (>10.0 mmol/L) were −2.3% (−13.1%, 8.5%) and 3.93% (−5.7%, 13.5%), respectively, and the median difference in time below range (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Clinical Affairs, Hedia Aps, Copenhagen, Denmark.
- Department of Endocrinology and Nephrology, Copenhagen University Hospital - North Zealand, Hillerød, Denmark.
- Steno Diabetes Center Copenhagen, Herlev, Denmark.
- Omicron ApS, Søborg, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Kenney Fehrenkamp Pedersen, Pernille Rudebeck Mogensen, Gaspar Letnar
Zitieren
APA
Fehrenkamp Pedersen, K., Mogensen, P. R., Olsen, M. T., Letnar, G., Kunckel, M. A., Laursen, D. H., & Lommer Kristensen, P. (2026). Impact of an Insulin Bolus Calculator on Glycemic Control in Relation to Exercise—A Crossover Randomized Controlled Trial. Diabetes Technology & Therapeutics. https://doi.org/10.1177/15209156251364547
Vancouver
Fehrenkamp Pedersen K, Mogensen PR, Olsen MT, Letnar G, Kunckel MA, Laursen DH, et al. Impact of an Insulin Bolus Calculator on Glycemic Control in Relation to Exercise—A Crossover Randomized Controlled Trial. Diabetes Technology & Therapeutics. 2026. doi:10.1177/15209156251364547
BibTeX
@article{FehrenkampPedersen2026,
author = {Fehrenkamp Pedersen, Kenney and Mogensen, Pernille Rudebeck and Olsen, Mikkel Thor and Letnar, Gaspar and Kunckel, Maria Amlund and Laursen, Ditte Hjorth and Lommer Kristensen, Peter},
title = {Impact of an Insulin Bolus Calculator on Glycemic Control in Relation to Exercise—A Crossover Randomized Controlled Trial},
journal = {Diabetes Technology & Therapeutics},
year = {2026},
doi = {10.1177/15209156251364547}
}
EUVIMED